243 related articles for article (PubMed ID: 18279479)
1. Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9.
Jiao Z; Ding JJ; Shen J; Liang HQ; Zhong LJ; Wang Y; Zhong MK; Lu WY
Br J Clin Pharmacol; 2008 Jun; 65(6):893-907. PubMed ID: 18279479
[TBL] [Abstract][Full Text] [Related]
2. The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.
Lévesque E; Delage R; Benoit-Biancamano MO; Caron P; Bernard O; Couture F; Guillemette C
Clin Pharmacol Ther; 2007 Mar; 81(3):392-400. PubMed ID: 17339869
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil.
Ling J; Shi J; Jiang Q; Jiao Z
Eur J Clin Pharmacol; 2015 Jan; 71(1):95-106. PubMed ID: 25327506
[TBL] [Abstract][Full Text] [Related]
4. C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation.
Baldelli S; Merlini S; Perico N; Nicastri A; Cortinovis M; Gotti E; Remuzzi G; Cattaneo D
Pharmacogenomics; 2007 Sep; 8(9):1127-41. PubMed ID: 17924828
[TBL] [Abstract][Full Text] [Related]
5. Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.
Zhang WX; Chen B; Jin Z; Yu Z; Wang X; Chen H; Mao A; Cai W
Xenobiotica; 2008 Nov; 38(11):1422-36. PubMed ID: 18946804
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers.
Guo D; Pang LF; Han Y; Yang H; Wang G; Tan ZR; Zhang W; Zhou HH
Eur J Clin Pharmacol; 2013 Apr; 69(4):843-9. PubMed ID: 23052409
[TBL] [Abstract][Full Text] [Related]
7. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.
Miura M; Kagaya H; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
Ther Drug Monit; 2008 Oct; 30(5):559-64. PubMed ID: 18695635
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis.
Yang CL; Sheng CC; Liao GY; Su Y; Feng LJ; Xia Q; Jiao Z; Xu DJ
J Clin Pharm Ther; 2021 Dec; 46(6):1564-1575. PubMed ID: 34312870
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: assessment of impact of cyclosporine dose in Asian renal transplant patients.
Yau WP; Vathsala A; Lou HX; Zhou S; Chan E
J Clin Pharmacol; 2009 Jun; 49(6):684-99. PubMed ID: 19386625
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.
Okour M; Jacobson PA; Ahmed MA; Israni AK; Brundage RC
J Clin Pharmacol; 2018 May; 58(5):628-639. PubMed ID: 29329489
[TBL] [Abstract][Full Text] [Related]
12. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
[TBL] [Abstract][Full Text] [Related]
13. Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients.
Xie XC; Li J; Wang HY; Li HL; Liu J; Fu Q; Huang JW; Zhu C; Zhong GP; Wang XD; Sun PP; Huang M; Wang CX; Li JL
Acta Pharmacol Sin; 2015 May; 36(5):644-50. PubMed ID: 25864649
[TBL] [Abstract][Full Text] [Related]
14. Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis.
Abd Rahman AN; Tett SE; Abdul Gafor HA; McWhinney BC; Staatz CE
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):993-1004. PubMed ID: 28536776
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
16. Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.
Sherwin CM; Sagcal-Gironella AC; Fukuda T; Brunner HI; Vinks AA
Br J Clin Pharmacol; 2012 May; 73(5):727-40. PubMed ID: 22053944
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Vulto AG; Shaw LM; Mathot RA
Clin Pharmacokinet; 2009; 48(7):463-76. PubMed ID: 19691368
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients.
Colom H; Lloberas N; Andreu F; Caldés A; Torras J; Oppenheimer F; Sanchez-Plumed J; Gentil MA; Kuypers DR; Brunet M; Ekberg H; Grinyó JM
Kidney Int; 2014 Jun; 85(6):1434-43. PubMed ID: 24402086
[TBL] [Abstract][Full Text] [Related]
19. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.
Geng F; Jiao Z; Dao YJ; Qiu XY; Ding JJ; Shi XJ; Li ZD; Zhong MK
Clin Chim Acta; 2012 Apr; 413(7-8):683-90. PubMed ID: 22227166
[TBL] [Abstract][Full Text] [Related]
20. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies.
Jiao Z; Zhong JY; Zhang M; Shi XJ; Yu YQ; Lu WY
Eur J Clin Pharmacol; 2007 Jan; 63(1):27-37. PubMed ID: 17093994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
